2022
Evaluation of TRPS1 Expression in Pleural Effusion Cytology Specimens With Metastatic Breast Carcinoma
Wang M, Stendahl K, Cai G, Adeniran A, Harigopal M, Gilani SM. Evaluation of TRPS1 Expression in Pleural Effusion Cytology Specimens With Metastatic Breast Carcinoma. American Journal Of Clinical Pathology 2022, 158: 416-425. PMID: 35760555, DOI: 10.1093/ajcp/aqac066.Peer-Reviewed Original ResearchMeSH KeywordsBiomarkers, TumorBreast NeoplasmsCarcinoma, Squamous CellFemaleHumansLung NeoplasmsPleural Effusion, MalignantRepressor ProteinsUrinary Bladder NeoplasmsConceptsTrichorhinophalangeal syndrome type 1Breast originMetastatic carcinomaTRPS1 expressionBreast primaryBreast carcinomaPrimary siteMC casesMetastatic breast carcinomaSquamous cell carcinomaPleural effusion cytologySyndrome type 1Cell block materialStrong nuclear expressionEffusion cytology specimensCell carcinomaUrothelial carcinomaIHC panelMalignant melanomaLung adenocarcinomaIHC stainingPositive stainingCytology specimensCarcinomaEffusion cytology
2019
Molecular Testing on Pleural Fluid Samples
Oh S, Ronaghi R, Cai G. Molecular Testing on Pleural Fluid Samples. Seminars In Respiratory And Critical Care Medicine 2019, 40: 340-346. PMID: 31525809, DOI: 10.1055/s-0039-1695702.Peer-Reviewed Original ResearchMeSH KeywordsAntineoplastic Agents, ImmunologicalBiochemical PhenomenaBiomarkers, TumorExudates and TransudatesHumansImmunohistochemistryMesotheliomaPleural Effusion, MalignantPrognosisConceptsPleural fluid analysisPleural effusionFluid analysisMalignant diseasePleural fluidMalignant pleural effusionPleural fluid samplesRoutine thoracentesisNonmalignant diseasesCommon manifestationAppropriate stagingCytologic evaluationSignificant prognosticTherapeutic implicationsMolecular testingEffusionTreatment implicationsDiseaseFluid samplesSignificant numberLow sensitivityThoracentesisEtiologyStagingCancer